Align Technology (ALGN) Common Equity (2009 - 2026)
Align Technology's (ALGN) quarterly Common Equity came in at $4.2 billion in Q2 2026, up 8.17% year-over-year from $3.9 billion in Q2 2025, and up 2.0% quarter-over-quarter from $4.1 billion in Q1 2026.
Analysis
Align Technology (ALGN) Common Equity (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has reported Common Equity for 18 consecutive years, with $4.2 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Common Equity rose 8.17% year-over-year to $4.2 billion in Q2 2026; TTM through Jun 2026 was $4.2 billion, a 8.17% increase from a year earlier, with the FY2025 full-year figure at $4.0 billion, up 5.12% from the prior year.
- Common Equity was $4.2 billion for Q2 2026 at Align Technology, up from $4.1 billion in the prior quarter.
- Over five years, Common Equity peaked at $4.2 billion in Q2 2026 and troughed at $3.5 billion in Q1 2023.
- A 5-year average of $3.8 billion and a median of $3.8 billion in 2024 frame the typical range for Common Equity.
- Across the five-year window, Common Equity decreased 5.09% in 2023 and advanced 9.36% in 2026, its largest moves.
- Over 5 years, Common Equity stood at $3.6 billion in 2022, then advanced by 0.81% to $3.6 billion in 2023, then grew by 6.1% to $3.9 billion in 2024, then increased by 5.12% to $4.0 billion in 2025, then rose by 4.53% to $4.2 billion in 2026.
- The last three Common Equity figures came in at $4.2 billion (Q2 2026), $4.1 billion (Q1 2026), and $4.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.72 Bn | 9.62 Bn | 757.43 Mn | 4.23 Bn |
| 2 | Envista Holdings | 4.21 Bn | 3.08 Bn | 407.00 Mn | 3.08 Bn |
| 3 | Dentsply Sirona | 2.10 Bn | 1.86 Bn | 493.00 Mn | 1.35 Bn |
| 4 | Milestone Scientific | 35.70 Mn | 33.09 Mn | 1.56 Mn | 2.28 Mn |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | -3.94 Mn |
| 6 | Vivos Therapeutics | 3.21 Mn | 1.41 Mn | 2.95 Mn | -3.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.23 Bn |
| Mar 31, 2026 | 4.15 Bn |
| Dec 31, 2025 | 4.05 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 3.91 Bn |
| Mar 31, 2025 | 3.79 Bn |
| Dec 31, 2024 | 3.85 Bn |
| Sep 30, 2024 | 3.94 Bn |
| Jun 30, 2024 | 3.76 Bn |
| Mar 31, 2024 | 3.76 Bn |
| Dec 31, 2023 | 3.63 Bn |
| Sep 30, 2023 | 3.80 Bn |
| Jun 30, 2023 | 3.64 Bn |
| Mar 31, 2023 | 3.48 Bn |
| Dec 31, 2022 | 3.60 Bn |
| Sep 30, 2022 | 3.69 Bn |
| Jun 30, 2022 | 3.60 Bn |
| Mar 31, 2022 | 3.67 Bn |
| Dec 31, 2021 | 3.62 Bn |
| Sep 30, 2021 | 3.52 Bn |